Bleeding Common Years After TAVR, and Deadly Bleeding Common Years After TAVR, and Deadly

Registry findings highlight an underappreciated risk after transcatheter aortic valve replacement -- late nonaccess site bleeding -- and the pressing need to fine-tune postprocedure anticoagulant and antiplatelet therapy.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news